Agneta Siegbahn
Impact in
- Internal Medicine top 0.2%
- Venous Thromboembolism Diagnosis and Management
-
- Atrial Fibrillation Management and Outcomes
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
Papers in
-
- Atrial Fibrillation Management and Outcomes 24
- Acute Myocardial Infarction Research 14
- Antiplatelet Therapy and Cardiovascular Diseases 10
-
- Extracellular vesicles in disease 10
- Co-authors
- Lars Wallentin (77 shared papers)Carl‐Henrik Heldin (13 shared papers)Bertil Lindahl (17 shared papers)Lena Claesson‐Welsh (7 shared papers)Per Venge (14 shared papers)Henrik Toss (5 shared papers)Masabumi Shibuya (1 shared paper)Johannes Waltenberger (1 shared paper)
- Journals
- Journal of the American College of Cardiology (17 papers)Thrombosis Research (15 papers)Thrombosis and Haemostasis (12 papers)Arteriosclerosis Thrombosis and Vascular Biology (10 papers)Circulation (9 papers)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Agneta Siegbahn
190 papers receiving 14.0k citations
Agneta Siegbahn's Hit Papers
Peers
Comparison fields: 5 of 153
- Internal Medicine 1.2k
- Cardiology and Cardiovascular Medicine 4.6k
- Immunology and Allergy 825
- Hematology 1.1k
- Immunology 1.8k
Countries citing papers authored by Agneta Siegbahn
This map shows the geographic impact of Agneta Siegbahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agneta Siegbahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agneta Siegbahn more than expected).
Fields of papers citing papers by Agneta Siegbahn
This network shows the impact of papers produced by Agneta Siegbahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agneta Siegbahn. The network helps show where Agneta Siegbahn may publish in the future.
Co-authors
The 25 scholars most cited alongside Agneta Siegbahn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 191 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. Hit paper breakdown → | 1994 | 1448 |
| 2 | Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery Disease Hit paper breakdown → | 2000 | 998 |
| 3 | 2001 | 473 | |
| 4 | 2003 | 458 | |
| 5 | Prognostic Influence of Increased Fibrinogen and C-Reactive Protein Levels in Unstable Coronary Artery Disease Hit paper breakdown → | 1997 | 442 |
| 6 | Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial Hit paper breakdown → | 2011 | 382 |
| 7 | 2012 | 314 | |
| 8 | 2013 | 306 | |
| 9 | Membrane ruffling and chemotaxis transduced by the PDGF beta-receptor require the binding site for phosphatidylinositol 3' kinase. | 1994 | 287 |
| 10 | 1997 | 276 | |
| 11 | 1988 | 248 | |
| 12 | 1994 | 247 | |
| 13 | 2014 | 244 | |
| 14 | 1992 | 240 | |
| 15 | 1992 | 234 | |
| 16 | 1990 | 228 | |
| 17 | 2013 | 218 | |
| 18 | 1996 | 216 | |
| 19 | 2013 | 215 | |
| 20 | 2000 | 204 |
About Agneta Siegbahn
Agneta Siegbahn is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Hematology, Immunology and Surgery, having authored 191 papers that have together received 14.5k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (29 papers), Atrial Fibrillation Management and Outcomes (24 papers), Cell Adhesion Molecules Research (14 papers), Acute Myocardial Infarction Research (14 papers), GDF15 and Related Biomarkers (11 papers), Venous Thromboembolism Diagnosis and Management (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (10 papers) and Extracellular vesicles in disease (10 papers). The work is most often cited by research in Internal Medicine (1.2k citations), Cardiology and Cardiovascular Medicine (4.6k citations), Immunology and Allergy (825 citations), Hematology (1.1k citations) and Immunology (1.8k citations). Agneta Siegbahn has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Lars Wallentin, Carl‐Henrik Heldin, Bertil Lindahl, Lena Claesson‐Welsh, Per Venge, Henrik Toss, Masabumi Shibuya, Johannes Waltenberger, Jonas Oldgren and Eva Lindmark. Their work appears in journals such as Journal of the American College of Cardiology, Thrombosis Research, Thrombosis and Haemostasis, Arteriosclerosis Thrombosis and Vascular Biology and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.